Health drugs could raise premiums

Article Abstract:

Sales of cholesterol-lowering drugs and health insurance premius in the US are expected to increase following the release on May May 15, 2001 of new health guidelines from the National Cholesterol Education Program (NCEP). The NCEP report that recommends increased screening and treatment shows how drugs are becoming increasingly used to fight diseases. Under the new NCEP guidelines, sales of such drugs could more than double because the number of US patients needing medication could increase from 16 million-36 million.

Forecasts, trends, outlooks, Pharmaceutical Preparation Manufacturing, Lipotropics & Cholesterol Reducers

---

Hospitals, patients run short of key drugs

Article Abstract:

Drug firms advise public not to worry about drug shortages, however hemophiliacs and their families often have only a day's supply of the drug that keeps them from bleeding to death. Snake-bite anti-venom is another drug in short supply.

Production data, Biological Product (except Diagnostic) Manufacturing, Biological products exc. diagnostic, Antihemophiliac Factor, Brief Article, Factor VIII

---

Fake drugs show up in U.S. pharmacies: As prescription prices rise, counterfeiters chase profits

Article Abstract:

Counterfeiters have successfully slipped fake, mislabeled and mishandled drugs into Unites States pharmacies, as more high-priced prescription medications hit the market in 2003. Pharmacists stated that the problem of counterfeit, mislabeling or mishandled drugs could spread beyond the relatively new medications affected unless state and federal regulators tighten requirements for the nation's drug wholesalers.

Legal issues & crime, Marketing procedures, Commodity & service prices, Illicit Drugs, Company legal issue, Prices and rates, Marketing, Investigations, Labeling, Company marketing practices, Illegal drugs, Company pricing policy, Counterfeiters

Similar abstracts:

• Abstracts: Lucent sales `holding up.'(CEO says reorganization has tightened controls on company's vendor spending.) Newbridge reassures jittery investors
• Abstracts: Black claims veto over Hollinger asset sales: Toronto-based parent company changes bylaws of Chicago subsidiary
• Abstracts: Loonie 'kicking butt' as rising rates, oil prices spur currency. Exports stage rebound in August
• Abstracts: New software, new scrutiny for Microsoft; U.S. and states consider Windows XP challenge. States press U.S. to take tough stand on Microsoft
• Abstracts: BMO to split CEO, chairman roles: Bank is last of the Big Six to separate the functions of key decision makers

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.